Recent Headlines
New LDL and VLDL Receptor Antibodies Released
Novus Biologicals announced today the release of new LDL Receptor (NBP1-78159) and VLDL Receptor (NBP1-78162) antibodies. LDL and VLDL Receptors are similar cell-surface receptor proteins which mediate endocytosis of cholesterol-rich lipoproteins. Both receptors are critical to the lipid and... - October 27, 2011 - Novus Biologicals
Bedford Research Foundation Hosts Ninth Annual Activated Egg Symposium
The Bedford Research Foundation is hosting the ninth annual Activated Egg Symposium, a yearly event that brings together experts in the stem cell research community to discuss their work, and form collaborations. The foundation's director, Dr. Ann Kiessling is proud to announce that this year's keynote speaker is Dr. Janet Rossant of the University of Toronto. The event is on November 4th, 2011 from 8am to 7:30pm. - October 26, 2011 - Bedford Stem Cell Research Foundation
Novus Biologicals Announces New PAR1 Antibody
Novus Biologicals announced today a new Thrombin Receptor antibody (catalog number NBP1-71770) for use in wound healing and cancer research. Thrombin Receptor, also known as Protease activated receptor 1 (PAR1), is a G-protein-coupled receptor that functions in blood clotting. While Thrombin... - October 26, 2011 - Novus Biologicals
PharmaJet FDA Regulatory Clearances on Its Needle-Free Injection Devices
PharmaJet has received two FDA 510(k) marketing clearances for its IM/SC injection technology. Below are the Indications For Use, cleared by the FDA. FDA 510(k) Number K111517: PharmaJet Stratis Needle-free Injection System: The PharmaJet Stratis Needle-free Injection System is intended to... - October 25, 2011 - PharmaJet, Inc.
Novus Biologicals Announces New SHDA Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new SDHA Antibody (catalog number NBP1-71688) for use in hypoxia research. This SHDA antibody was made using SDIX Genomic Antibody TechnologyTM. Localized within the mitochondrial inner membrane, Succinate Dehydrogenase A (SDHA) is an important component in the... - October 23, 2011 - Novus Biologicals
Semprus BioSciences Awarded $1 Million U.S. Army Grant to Develop "Anti-Biofilm Trauma Devices" for American Soldiers in Battle
Semprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation, the foundation for most bacterial complications associated with medical device implants. - October 21, 2011 - Semprus BioSciences
Novus Biologicals Announces New Dicer1 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new DICER1 antibody (catalog number NBP1-71691) for use in cell cycle and replication and cancer research. This DICER1 antibody was made using SDIX Genomic Antibody TechnologyTM. DICER1 is a ribonuclease that has been extensively shown to be related to cancer. - October 20, 2011 - Novus Biologicals
Novus Focuses on Supplying Quality Antibodies for Model Organism Research
Novus is a leading supplier of research antibodies that have been validated for use in model organisms, and they have recently expanded their selection of top quality reagents for Drosophila melanogaster, Caenorhabditis elegans, and Xenopus laevis. These three model organisms are commonly used in... - October 15, 2011 - Novus Biologicals
Stevens Mass Spectrometry Reveals Evolution of Insect Biochemistry
Dr. Attygalle provides new insight into how certain parasites locate host ants. - October 15, 2011 - Stevens Institute of Technology
MMS Announces Strategic Alliance with TransPerfect
MMS Holdings Inc. announces a strategic alliance with TransPerfect, the world's largest privately held provider of language services and technology, to offer translation and interpretation services to their clients across global clinical programs. These services are complimentary to those offered... - October 15, 2011 - MMS Holdings Inc.
Novus Announces Two Contest Winners
Novus Biologicals announced today the winners of two customer contests. First, the third quarter Novus Travel Grant winner is Dr. Toryn Poolman of the University of Manchester's School of Medicine, selected for his excellent review of our Glucocorticoid Receptor Antibody (NB300-610). Dr. Poolman... - October 14, 2011 - Novus Biologicals
New EpiPlus - Histone Modification Antibodies Announced Today
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - October 12, 2011 - Novus Biologicals
Embedded Nanotechnology Devices for Monitoring National Infrastructure
Stevens engineers have demonstrated PZT nanofiber devices for use as embedded sensors. - October 08, 2011 - Stevens Institute of Technology
Optimizing Offshore Wind Energy Funded by DoE
Stevens Institute of Technology receives a Department of Energy grant to make wind a more viable solution for America's energy needs. - October 07, 2011 - Stevens Institute of Technology
Two New Lamin A + C Antibodies Announced by Novus Biologicals
Novus Biologicals announced today two new Lamin A+C antibodies for use in epigenetic research and for certain cancer research. Lamins and lamin-associated proteins help shape the nucleus and provide a scaffold-type support system for chromosomes and replicating DNA to interact with epigenetic... - October 06, 2011 - Novus Biologicals
Novus Biologicals Announces New LAMP2 Antibody Made Using SDIX Genomic Antibody Technology™
Novus Biologicals announced today a new LAMP2 antibody (catalog number NBP1-71692) for use as a cell marker in autophagy signaling and cancer research. This LAMP2 antibody was developed using SDIX Genomic Antibody TechnologyTM. LAMP2 is a member of a family of membrane glycoproteins. Specifically,... - October 05, 2011 - Novus Biologicals
Bioo Scientific is Launching the NEXTflex-96™ DNA Barcodes to Significantly Increase NGS Throughput
Today Bioo Scientific announced the launch of the NEXTflex-96™ DNA Barcodes, which significantly increases next generation sequencing throughput by using barcoded indices to run multiple samples in parallel. The ability to increase the scale of next generation sequencing (NGS) is a critical... - October 01, 2011 - Bioo Scientific
New Group of EpiPlus Histone Modification Antibodies Released
Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated... - September 30, 2011 - Novus Biologicals
New Kit For Improved Protein Solubility Launched
Dilyx Biotechnologies, LLC announces the launch of the OptiResc Protein Aggregate Solubilization Kit, allowing research scientists to rescue inadvertently aggregated protein samples. The kit saves effort and money because it helps life the science researchers to continue work on protein samples,... - September 30, 2011 - Dilyx Biotechnologies LLC
Stevens Institute of Technology Wins NSF Nanotechnology Undergraduate Education Grant
NUE-NEXUS program to give undergraduates early-curriculum classroom instruction and research opportunities in nanotechnology field. - September 29, 2011 - Stevens Institute of Technology
New Argentine Distributor Announced by Novus Biologicals
Novus Biologicals announced today a new distributor partnership in Argentina with Migliore Laclaustra, S.R.L. Argentina is a biotechnology leader in Latin America, with more than 80 multinational corporations and local companies currently operating nationally. The combination of a highly qualified... - September 29, 2011 - Novus Biologicals
Bioo Scientific and Jungwoo F&B to Collaborate to Improve Cancer Diagnosis and Treatment
Bioo Scientific has been invited to be a guest of The University of Texas at Austin for the UT Gyeonggi Innovation Program which is being sponsored by Governor Kim Moon-Soo, of the Gyeonggi Province, Korea. The UT Gyeonggi Innovation Program is a 3-year program to promote entrepreneurship, identify... - September 28, 2011 - Bioo Scientific
America’s Pascarella Earns Superstock 600 European Championship Wild Card Ride
Globetrotting Joey Pascarella has accepted a wild card opportunity in the upcoming Superstock 600 European Championship round scheduled for September 24th in Imola, Italy. San Francisco based consulting firm, Jon Block Group and Italian race team, Ciatti Racing will provide principal sponsorship... - September 23, 2011 - Jon Block Group
Kroger Launches Flu Shot Campaign with PharmaJet Needle-free Injection Devices
Kroger will offer the PharmaJet needle-free injection option at over 800 Kroger and The Little Clinics locations nationwide. - September 23, 2011 - PharmaJet, Inc.
ByoPlanet International LLC, a Leader in the Elimination of Health-Threatening Pathogens, Has Affiliated Itself with Safe & Secure TV Channel LLC
With death tolls, human illness, and medical costs soaring sky high, we might have just pinpointed the next global terrorists - microbial pathogens. Nowhere is safe, as outbreaks wreak havoc in our schools, hospitals, airports, hotels, public transportation, health clubs, and restaurants. If only there was some new, cutting edge technology to eliminate the dangerous bacteria and viruses - Enter ByoPlanet, the global sanitizing super hero for the 21st century. - September 22, 2011 - ByoPlanet International, LLC
Semprus BioSciences Appoints Alonzo D. Cook, Ph.D. Group Leader, Research
Semprus BioSciences today announced the appointment of Alonzo (Lon) D. Cook, Ph.D., to the newly-created post of Group Leader, Research, effective immediately. - September 22, 2011 - Semprus BioSciences
New Histone H3 [dimethyl Lys9/phospho Thr6] Antibody Released
Today, Novus added a new Histone H3 [dimethyl Lys9/phospho Thr6] antibody to their growing line of EpiPlusTM histone modification antibodies. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate... - September 21, 2011 - Novus Biologicals
NSF Grant Supports Graphene Nanoelectronics Research at Stevens
NSF awards a grant to advance nanoelectronic sensors through graphene. - September 21, 2011 - Stevens Institute of Technology
Bioo Scientific Will Participate in the 2011 AOAC International Annual Meeting
Bioo Scientific announced that it will feature its industry-leading food safety testing kits at the 125th AOAC Annual Meeting in New Orleans being held September 18th – 21st. AOAC is an independent, third party organization, which brings credibility to analytical methods used for regulation... - September 17, 2011 - Bioo Scientific
Swarm Intelligence Enables Better Nerve Grafts
NIH funded collaborative research adds computational models of swarm intelligence based neural networks to tissue engineering. - September 17, 2011 - Stevens Institute of Technology
Stevens and LeHigh Developing Nanotechnology for Better Natural Gas Utilization
Advances in understanding molybdenum nanostructures and molecular mechanisms of catalytic reactions to provide improved natural gas processing technologies. - September 15, 2011 - Stevens Institute of Technology
Applying New Mathematics for Robust Cryptography and a Safer Internet
Computer security experts are piggy-backing on recent developments in mathematics to pioneer new cryptography methods that will keep data safe even in the age of superfast quantum computing. - September 14, 2011 - Stevens Institute of Technology
Novus Biologicals Announces New NODAL Antibody Made Using SDIX Genomic Antibodiy Technology™
Novus Biologicals announced today a new NODAL antibody (catalog number NBP1-71686) for the study of cancer, angiogenesis and stem cells. This NODAL antibody was made using SDIX Genomic AntibodiesTM (GATTM). This NODAL Antibody (NBP1-71686) serves as an excellent tool for studying stem cell... - September 11, 2011 - Novus Biologicals
Stevens Convocation 2011 Celebrates Students and Faculty
Faculty and students award citations from Stevens Convocation, September 7, 2011. - September 10, 2011 - Stevens Institute of Technology
Stevens Researchers Pioneer Novel Technique to Make Plasmonic Nanogap Arrays
Dr. Stefan Strauf, et al. published a paper on leveraging holographic lithography for fabricating nanogap arrays with features 70 times smaller than the wavelengths of the blue laser light used to create the nanostructures. - September 08, 2011 - Stevens Institute of Technology
Dr. Kishore Pochiraju of Stevens Co-Authors Book on Polymeric Matrix Composites
To help engineers design longer-lasting high-performance plastics, the forthcoming book, Long-Term Durability of Polymeric Matrix Composites, presents a holistic guide to environmental degradation, damage evolution, design, and application specific issues of long term structural durability. - September 03, 2011 - Stevens Institute of Technology
ONR Funds Dr. Chang-Hwan Choi to Study Nanoscale Wetting Dynamics of Superhydrophobic Surfaces at Stevens
Dr. Choi's DURIP grant supports development of innovative anti-corrosion materials. - September 01, 2011 - Stevens Institute of Technology
Synpromics Teams with Scottish Enterprise to Accelerate Growth
Synpromics Ltd announces the formal support of Scottish Enterprise’s High Growth Start-Up Unit (HGSU). Synpromics intends to leverage this valuable affiliation to help drive growth as the company transitions from a start-up business to an established globally-focused corporation in the future. - August 31, 2011 - Synpromics Ltd
Bioo Scientific Launches Benzo[a]pyrene ELISA to Rapidly Screen Food for Oil Spill Contaminants
The recently released MaxSignal® Benzo[a]pyrene ELISA Kit offers rapid screening of benzo[a]pyrene, a carcinogenic component of petroleum, in fish, shrimp, meat and water samples. - August 23, 2011 - Bioo Scientific
Solar Photovoltaic Installation Workshop at Stevens on August 25
Stevens Institute of Technology is offering a PV installation workshop on August 25 at the build site for the Empowerhouse Solar Decathlon Competition entry. - August 20, 2011 - Stevens Institute of Technology
Dr. Michael Bruno of Stevens Edits Maritime Security Journal Lauded by DHS
The US Department of Homeland Security praised the May/June 2011 issue of the Marine Technology Society Journal as guest edited by Dr. Bruno from Stevens Institute of Technology. - August 20, 2011 - Stevens Institute of Technology
Novus Releases New Mix-and-Match Pathway Assay Kits
Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a... - August 18, 2011 - Novus Biologicals
MoBiTec GmbH, Germany, is Offering Nuclear Receptor Fusion Proteins That Are of Importance to the Pharmaceutical Industry for FRET Interaction Studies
MoBiTec GmbH, Germany, supplier of research tools, introduces a collection of Nuclear Receptor-Ligand Binding Domain fusion proteins, carrying a GST tag, capable to bind a Europium-anti-GST antibody. With this the influence of fluorophore-labeled peptides on the ligand binding characteristics can be studied. E.g. the addition of a particular peptide might prevent the receptor from binding a ligand, thereby eliminating a response of a cell to a given stimulus. - August 17, 2011 - MoBiTec GmbH
Mouse Monoclonal DUX4 Antibody Announced by Novus Biologicals
DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD... - August 17, 2011 - Novus Biologicals
Professor Attygalle of Stevens Lectures at a Max Planck Institute on Mass Spectrometry
Mass spectrometry expert Dr. Athula Attygalle from Stevens Institute of Technology lectured at a Max Planck Institute in Jena, Germany, earlier this summer. - August 11, 2011 - Stevens Institute of Technology
Mitegen Announces Distribution of AP Innovation's Quick Puck Loader
Innovative Tool increases speed and reduces errors during puck loading - August 03, 2011 - MiTeGen, LLC
Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals
Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals
AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody
Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011 - AbboMax, Inc.
Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™
Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals
Dr. Chandramouli of Stevens Gives Keynote on Dynamic Spectrum Access at Wireless Security Conference
Dr. R. Chandramouli of Stevens gave the Wireless Summit track keynote lecture, “Dynamic Spectrum Access Wireless Networking," at the NIKSUN World Wide Security & Mobility Conference 2011 (NIKSUN WWSMC) in Princeton, NJ, on July 27. - July 29, 2011 - Stevens Institute of Technology